Bavarian Nordic Logo

Bavarian Nordic

A biotech firm developing and manufacturing life-saving vaccines for travel and public health.

BAVA | CO

Overview

Corporate Details

ISIN(s):
DK0015998017 (+1 more)
LEI:
2138006JCDVYIN6INP51
Country:
Denmark
Address:
PHILIP HEYMANS ALLE 3, 2900 HELLERUP
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bavarian Nordic is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company specializes in preventing infectious diseases through innovative vaccine technologies. It serves as a leading global provider of travel vaccines and is a key partner for governments and international organizations in delivering public health solutions. Bavarian Nordic manages the entire product lifecycle, from initial research and development through to large-scale manufacturing and distribution.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 14:07
M&A Activity
English 148.1 KB
2025-10-31 14:07
M&A Activity
Danish 19.9 KB
2025-10-31 14:07
M&A Activity
English 158.1 KB
2025-10-31 14:07
M&A Activity
Danish 173.8 KB
2025-10-31 14:07
M&A Activity
English 19.2 KB
2025-10-31 14:07
M&A Activity
Danish 136.4 KB
2025-10-31 09:14
Regulatory News Service
English 7.7 KB
2025-10-31 09:14
Regulatory News Service
Danish 7.0 KB
2025-10-31 09:14
Regulatory News Service
Danish 185.5 KB
2025-10-31 09:14
Regulatory News Service
English 167.0 KB
2025-10-29 13:29
Major Shareholding Notification
Danish 112.2 KB
2025-10-29 13:29
Major Shareholding Notification
English 2.9 KB
2025-10-29 13:29
Major Shareholding Notification
English 188.3 KB
2025-10-29 13:29
Major Shareholding Notification
Danish 2.8 KB
2025-10-21 14:46
M&A Activity
Danish 175.9 KB

Automate Your Workflow. Get a real-time feed of all Bavarian Nordic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bavarian Nordic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bavarian Nordic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MYUNGMOON PHARM CO.,LTD Logo
Develops, manufactures, and commercializes prescription & OTC medicines for global markets.
South Korea 017180
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanobiotix Logo
Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.
France NANO
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland NNG
NanoRepro AG Logo
Develops and distributes rapid diagnostic self-tests for early disease detection.
Germany NN6
NATAC Logo
Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.
Spain NAT
Biotech R&D of natural ingredients for health and wellness solutions.
South Korea 168330
Naturland Holding PLC Logo
A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.
United Kingdom NATUR
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America 950220

Talk to a Data Expert

Have a question? We'll get back to you promptly.